Thomas Vanassche

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Jan Steffel, Rónán Collins, Matthias Antz et al. · EP Europace · 2021 · 1K citations · Full text

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

Thrombosis, Cardiovascular Disease, Stroke +13

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

James D. Douketis, Alex C. Spyropoulos, Joanne Duncan et al. · JAMA Internal Medicine · 2019 · 474 citations · Full text

Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES

Thomas Vanassche, Mandy N. Lauw, John W. Eikelboom et al. · European Heart Journal · 2014 · 311 citations · Full text

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10